MARKET

ICUCW

ICUCW

SeaStar Medical
NASDAQ
0.0164
-0.0001
-0.61%
After Hours: 0.0149 -0.0015 -9.15% 17:45 06/26 EDT
OPEN
0.0164
PREV CLOSE
0.0165
HIGH
0.0164
LOW
0.0164
VOLUME
4.25K
TURNOVER
--
52 WEEK HIGH
0.0750
52 WEEK LOW
0.0084
MARKET CAP
--
P/E (TTM)
-0.0034
1D
5D
1M
3M
1Y
5Y
1D
SeaStar Medical amends prior 8-K on ex-CEO Green separation payout, says settlement exceeds earlier disclosure
PUBT · 4d ago
SeaStar Medical announces new CD-10-PCS codes for SCD therapy
TipRanks · 5d ago
SeaStar Medical's Selective Cytopheretic Device Receives Dedicated International Classification of Diseases Codes From U.S. CMS, Facilitating Future Billing Procedures
Benzinga · 5d ago
SEASTAR MEDICAL HOLDING CORP - NEW ICD-10-PCS CODES EFFECTIVE OCTOBER 1, 2026
Reuters · 5d ago
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
Barchart · 5d ago
SeaStar Medical CEO to present at Virtual Investor Summit Conference
PUBT · 6d ago
Weekly Report: what happened at ICU last week (0615-0619)?
Weekly Report · 6d ago
SeaStar Medical to Present at Upcoming Investor Summit Conference
Barchart · 6d ago
More
About ICUCW
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.

Webull offers SeaStar Medical Holding Corp stock information, including NASDAQ: ICUCW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICUCW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICUCW stock methods without spending real money on the virtual paper trading platform.